Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors.

Affiliation

Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH. Electronic address: [Email]

Abstract

Myalgia and arthralgia immune-related adverse events (irAEs) in patients treated with checkpoint inhibitors (CPIs) present a clinical challenge. We describe the clinical characteristics and treatment of myalgia and arthralgia irAEs in CPI-treated patients with genitourinary (GU) malignancies.

Keywords

Arthralgia,Immune-related adverse events,Immunotherapy,Renal cell carcinoma,Urothelial carcinoma,

OUR Recent Articles